Adverse drug reactions in neonates hospitalized in neonatal intensive care units in Barranquilla, Colombia
Abstract
Introduction: The appearance of adverse drug reactions in neonates is an important issue due to the lack of drug safety data.
Objective: To identify the behavior of adverse drug reactions (ADR) in hospitalized neonates at two intensive care units in Barranquilla, Colombia.
Materials and methods: We conducted a cross-sectional prospective descriptive study based on patientcentered intensive pharmacosurveillance. We followed up and monitored the appearance of ADRs for six months. We used Naranjo’s algorithm to assess causality, modified Hartwig and Siegel assessment scale to establish severity and Schumock and Thornton criteria to determine ADR preventability.
Results: We detected 123 adverse drug reactions in 78 neonates of the 284 monitored. The cumulative incidence of ADRs was 27.4% (78/284); incidence density was 30.60 ADRs per 1,000 patients/day (78/2,549). The most affected organ system was the digestive (33.6%). Systemic anti-infective drugs were the most involved pharmacological group. Most of the ADRs were mild (58.5%), 83% were classified as probable, 16.2% as possible and 0.8% as definite.
Conclusions: ADR incidence was high in newborns, and it increased in preterm infants (less than 38 weeks of age).
Downloads
References
Uppsala Monitoring Centre. Glossary of terms used in pharmacovigilance: Uppsala Monitoring Centre-2011. Fecha de consulta: 12 de febrero de 2015. Disponible en:
http://who-umc.org/Graphics/24729.pdf
Hennessy S, Strom BL. PDUFA reauthorization--drug safety’s golden moment of opportunity? N Engl J Med. 2007;356:1703-4. http://dx.doi.org/10.1056/NEJMp078048
Vallano A, Cereza G, Pedròs C, Agustí A, Danés I, Aguilera C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60:653-8. http://dx.doi.org/10.1111/j.1365-2125.2005.02504.x
Star K, Edwards IR. Pharmacovigilance for children’s sake. Drug Safety. 2014;37:91-8. http://dx.doi.org/10.1007/s40264-013-0133-8
Star K, Noren GN, Nordin K, Edwards IR. Suspected adverse drug reactions reported for children worldwide: An exploratory study using VigiBase. Drug Safety. 2011;34:415-28. http://dx.doi.org/10.2165/11587540-000000000-00000
Reiter PD. Neonatal pharmacology and pharmacokinetics. NeoReviews. 2002;3:e229-36. http://dx.doi.org/10.1542/neo.3-11-e229
Morselli PL. Clinical pharmacokinetics in neonates. Clin Pharmacokinet. 1976;1:81-98. http://dx.doi.org/10.2165/00003088-197601020-00001
Milsap RL, Jusko WJ. Pharmacokinetics in the infant. Environ Health Perspect. 1994;102:107-10.
Allegaert K, Anker JN. Adverse drug reactions in neonates and infants: A population-tailored approach is needed. Br J Clin Pharmacol. 2015;80:788-95. http://dx.doi.org/10.1111/bcp.12430
Chien JY, Ho RJ. Drug delivery trends in clinical trials and translational medicine: Evaluation of pharmacokinetic properties in special populations. J Pharm Sci. 2011;100:53-8. http://dx.doi.org/10.1002/jps.22253
World Health Organization. Promover la seguridad de los medicamentos para niños – 2007. Fecha de consulta: 12 de febrero de 2015. Disponible en: http://whqlibdoc.who.int/publications/2007/9789241563437_spa.pdf
Aagaard L, Weber CB, Hansen EH. Adverse drug reactions in the paediatric population in Denmark: A retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf. 2010;33:327-40. http://dx.doi.org/10.2165/11319100-000000000-00000
Shepherd G, Mohorn P, Yacoub K, May DW. Adverse drug reaction deaths reported in United States vital statistics, 1999-2006. Ann Pharmacother. 2012;46:169-75. http://dx.doi.org/10.1345/aph.1P592
Vallejos A. Reacciones adversas por antibióticos en una unidad de cuidado intensivo pediátrico y neonatal de Bogotá. Biomédica. 2007;27:66-75. http://dx.doi.org/10.7705/biomedica.v27i1.234
International Council on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use - ICH. E2D; Post-approval safety data
management: Definitions and standards for expedited reporting, 2.1. Adverse events - 2004. Fecha de consulta: 12 de abril de 2015. Disponible en: http://www.ich.org/
fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2D/Step4/E2D_Guideline.pdf
Naranjo C, Busto U, Sellers E, Sandor P, Ruiz I, Roberts E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-45. http://dx.doi.org/10.1038/clpt.1981.154
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229-32.
Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27:538-538.
Ceci A, Giaquinto C, Aboulker JP, Baiardi P, Bonifazi F, Della Pasqua O, et al. The Task-force in Europe for Drug Development for the Young (TEDDY) Network of
Excellence. Pediatr Drugs. 2009;11:18-21. http://dx.doi.org/10.2165/0148581-200911010-00008
World Health Organization. Guidelines for ATC Classification and DDD Assignment – 1996. Fecha de consulta: 12 de febrero de 2015. Disponible en: http://www.whocc.no/atc_ddd_index/
Jiménez R, Smith A, Carleton B. New ways of detecting ADRs in neonates and children. Curr Pharm Des. 2015;21:5643-9. http://dx.doi.org/10.2174/1381612821666150901
Belén A, Arruza L, Pacheco E, Portoles A, Diz J, Vargas E. Adverse drug reactions in neonates: A prospective study. Arch Dis Child. 2016;101:371-6. http://dx.doi.org/10.1136/archdischild-2015-309396
Sharek PJ, Horbar JD, Mason W, Bisarya H, Thurm CW, Suresh G, et al. Adverse events in the neonatal intensive care unit: Development, testing, and findings of an NICUfocused trigger tool to identify harm in North American NICUs. Pediatrics. 2006;118:1332-40. http://dx.doi.org/10.1542/peds.2006-0565
dos Santos DB, Coelho HL. Adverse drug reactions in hospitalized children in Fortaleza, Brazil. Pharmacoepidemiol Drug Saf. 2006;15:635-40. http://dx.doi.org/10.
/pds.1187
Rashed AN, Wong IK, Cranswick N, Tomlin S, Rascher W, Neubert A. Risk factors associated with adverse drug reactions in hospitalised children: International multicentre study. Eur J Clin Pharmacol. 2012;68:801-10. http://dx.doi.org/10.1007/s00228-011-1183-4
Martínez-Mir I, García-López M, Palop V, Ferrer JM, Rubio E, Morales-Olivas FJ. A prospective study of adverse drug reactions in hospitalized children. Br J Clin
Pharmacol. 1999;47:681-8. http://dx.doi.org/10.1046/j.1365-2125.1999.00943.x
Blanco-Reina E, Medina-Claros AF, Vega-Jiménez MA, Ocaña-Riola R, Márquez-Romero EI, Ruiz-Extremera A. Drug utilization pattern in children and off-label use
of medicines in a pediatric intensive care unit. Med Intensiva. 2016;40:1-8. http://dx.doi.org/10.1016/j.medine.2014.11.007
Temple ME, Robinson RF, Miller JC, Hayes JR, Nahata MC. Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf. 2004;27:819-29. http://dx.doi.org/10.2165/00002018-200427110-00005
Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP. Preventing adverse drug events in hospitalized patients. Ann Pharmacother. 1994;28:523-7. http://dx.doi.org/10.1177/106002809402800417
Tribiño G, Maldonado C, Segura O, Díaz J. Costos directos y aspectos clínicos de las reacciones adversas a medicamentos en pacientes hospitalizados en el servicio
de medicina interna de una institución de tercer nivel de Bogotá. Biomédica. 2006;26:31-41. http://dx.doi.org/10.7705/biomedica.v26i1.1392
Mendes JI, Polónia JM, Figueiras AG, Costa CM, Herdeiro MT. Nurses’ attitudes and spontaneous adverse drug reaction reporting: A case-control study in Portugal.
J Nurs Manag. 2016;24:409-16. http://dx.doi.org/10.1111/jonm.12337
Some similar items:
- Jorge Enrique Machado-Alba, Manuel José Londoño-Builes, Luis Felipe Echeverri-Cataño, Sergio Andrés Ochoa-Orozco, Adverse drug reactions in Colombian patients, 2007-2013: Analysis of population databases , Biomedica: Vol. 36 No. 1 (2016)
- Jorge E. Machado-Alba, Luis Felipe Echeverri-Cataño, Manuel José Londoño-Builes, Paula Andrea Moreno-Gutiérrez, Sergio Andrés Ochoa-Orozco, Joaquín Octavio Ruiz-Villa, Social, cultural and economic factors associated with self-medication , Biomedica: Vol. 34 No. 4 (2014)
- Constanza Pardo, Ricardo Cendales, Survival analysis of cervical cancer patients , Biomedica: Vol. 29 No. 3 (2009)
- Raúl Murillo, Ricardo Cendales, Carolina Wiesner, Marion Piñeros, Sandra Tovar, Effectiveness of cytology-based cervical cancer screening in the Colombian health system , Biomedica: Vol. 29 No. 3 (2009)
- Sandra Lorena Girón, Julio César Mateus, Fabián Méndez, Impact of an open waste disposal site on the occurrence of respiratory symptoms and on health care costs of children , Biomedica: Vol. 29 No. 3 (2009)
- José Joaquín Carvajal, Ligia Inés Moncada, Mauricio Humberto Rodríguez, Ligia del Pilar Pérez, Víctor Alberto Olano, Characterization of Aedes albopictus (Skuse, 1894) (Diptera:Culicidae) larval habitats near the Amazon River in Colombia , Biomedica: Vol. 29 No. 3 (2009)
- Andrés Páez, Gloria Rey, Carlos Agudelo, Alvaro Dulce, Edgar Parra, Hernando Díaz-Granados, Damaris Heredia, Luis Polo, Outbreak of urban rabies transmitted by dogs in Santa Marta, northern Colombia , Biomedica: Vol. 29 No. 3 (2009)
- Patricia Escobar, Katherine Paola Luna, Indira Paola Hernández, César Mauricio Rueda, María Magdalena Zorro, Simon L. Croft, In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole , Biomedica: Vol. 29 No. 3 (2009)
- Jaime E. Bernal, Martha Lucía Tamayo , Ignacio Briceño , Escilda Benavides , Newborn screening in Colombia: The experience of a private program in Bogotá , Biomedica: Vol. 44 No. 1 (2024)
- Mauricio Beltrán, María Cristina Navas, María Patricia Arbeláez, Jorge Donado, Sergio Jaramillo, Fernando De la Hoz, Cecilia Estrada, Lucía del Pilar Cortés, Amalia de Maldonado, Gloria Rey, Seroprevalence of hepatitis B virus and human immunodeficiency virus infection in a population of multiply-transfused patients in Colombia , Biomedica: Vol. 29 No. 2 (2009)
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
